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Abstract
Potential applications for gene-based tissue engineering therapies in the oral and maxillofacial
complex include the delivery of growth factors for periodontal regeneration, pulp capping/dentin
regeneration, and bone grafting of large osseous defects in dental and craniofacial reconstruction.
Part 1 reviewed the principals of gene-enhanced tissue engineering and the techniques of
introducing DNA into cells. This manuscript will review recent advances in gene-based therapies
for dental hard tissue regeneration, specifically as it pertains to dentin regeneration/pulp capping
and periodontal regeneration.
i. Introduction
The goal of gene-enhanced tissue engineering is to regen-
erate lost tissue by the local delivery of cells that have been
genetically-enhanced to deliver physiologic levels of spe-
cific growth factors. The basis for this approach lies in the
presence of a population of progenitor cells that can be
induced, under the influence of these growth factors, to
differentiate into the specific cells required for tissue
regeneration, with guidance from local cues in the wound
environment [1].
From a tissue engineering approach, the oral cavity has
significant advantages compared to other sites in the
body, including easy access and observability. Potential
applications for gene-based tissue engineering therapies
in the oral and maxillofacial complex include the delivery
of growth factors for periodontal regeneration, pulp cap-
ping/dentin regeneration, treatment of malignant neo-
plasms of the head and neck [2], regeneration for bone
grafting of large osseous defects in dental and craniofacial
reconstruction (e.g. bone augmentation prior to pros-
thetic reconstruction, fracture repair, and repair of facial
bone defects secondary to trauma, tumor resection, or
congenital deformities), and articular cartilage repair
[3,4].
This manuscript will review recent advances in gene-based
therapies for dental hard tissue regeneration, specifically
as it pertains to dentin regeneration/pulp capping and
periodontal regeneration.
ii. Gene-based therapies for dentin/pulp 
regeneration
A. Background
The goal of modern restorative dentistry is to functionally
and cosmetically restore lost tooth structure. Destroyed
coronal tooth structure, most commonly resulting from
dental caries, is currently restored using metal or polymer-
based materials; primarily silver amalgam, resin-based
composites and metal or porcelain crowns. Although
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these conventional restorative materials have proven to be
highly effective at preserving teeth, they have a limited
life-span and ultimately require replacement. It is esti-
mated that in the United States alone, close to 200 million
restorations, or 2/3 of all restorations placed by dentists,
involve the replacement of failed restorations [5]. Moreo-
ver, a significant percentage of these restored teeth ulti-
mately undergo pulpal necrosis, requiring either tooth
extraction or endodontic treatment and prosthetic
buildup. Therefore, development of novel techniques to
regenerate, as opposed to repairing, lost tooth structure
would have significant benefits.
Potential applicability of any dental hard tissue regenera-
tive protocol could include the regeneration of an entire
missing tooth or the regeneration of specific components
of an otherwise viable tooth (e.g. a decayed tooth with
early pulpal involvement). The lack of any enamel form-
ing cells in the enamel of fully developed erupted teeth
precludes the potential for cell-based approaches for
enamel regeneration.
In contrast, the regeneration of dentin is feasible because
dentin is in intimate contact with an underlying highly
vascular and innervated pulpal tissue, forming a tightly-
regulated "dentin-pulp complex". During primary tooth
formation, dentin is produced by odontoblastic cells
located within the pulp. Following tooth eruption, the
secretory activity of these cells is down-regulated,
although they continue to produce secondary dentine at a
low level. Pulpal tissue retains a limited potential to repair
itself following various insults. These healing stages in the
pulp resemble those of other hard tissues. Depending on
a number of poorly defined factors, surviving post-mitotic
odontoblastic cells can secrete tertiary dentin, a process
known as reactionary or reparative dentinogenesis, or,
alternatively, perivascular progenitor cells in the pulp can
be triggered to differentiate into odontoblastic-like cells
under the influence of specific growth factors [6,7].
Of the numerous growth factors normally expressed dur-
ing primary odontogenesis (for a review of these factors,
see [8]), members of the transforming growth factor beta
(TGF-beta) superfamily, including several members of the
bone morphogenetic protein family (e.g. BMP-2, BMP-7),
and insulin-like growth factor-1 (IGF-1) appear to play a
key part in the induction of odontoblast-like cell differen-
tiation from progenitor pulpal cells [9-12]. A number of
these growth factors are incorporated into the developing
dentin matrix during initial tooth formation, forming a
reservoir from which they can be released following den-
tin breakdown.
The origin of pulpal progenitor cells remains elusive,
although recent evidence suggests that they are associated
with the smooth muscle cells and pericytes of pulpal
blood vessels [13]. Migration of these newly proliferating
stem cells to the injury site may, in part, be mediated by
endothelial injury [14]. Glucocorticosteroids may also
play a role in promoting differentiation of pulpal
multipotential mesenchymal progenitor cells into odon-
toblast-like cells [15].
B. Conventional techniques for inducing pulpal repair
Calcium hydroxide has long been the "gold standard" for
pulp capping [16]. Its effectiveness at promoting dentinal
bridge formation over small pulpal exposure sites is
believed to be related to a combination of antimicrobial
activity (attributed to high pH) and its ability to stimulate
tertiary dentin formation (attributed to the release of cal-
cium ions). Recently, mineral trioxide aggregate (MTA)
has been proposed as an alternative to calcium hydroxide
for pulp capping. In vitro [17] and in vivo studies [18] sug-
gest that MTA may be more effective at inducing dental
hard tissue formation than calcium hydroxide, possibly
via a physicochemical reaction in which released calcium
ions react with tissue phosphates to form hydroxyapatite.
C. Research methodologies
Tooth organ culture techniques can be used for short-term
in vitro applications. However, an animal model is needed
to assess the long-term feasibility of GETE approaches to
dental hard tissue regeneration because the regenerative
process involves the interplay between several tightly reg-
ulated biologic systems including the host immune
response, hormonal control, and poorly-defined growth
factors.
Commonly used animal models for examining the effects
of pulp capping agents on teeth include the dog [19],
monkey [20], ferret [21], and rat [22]. Lagomorphs, such
as the rabbit, have also been used [23,24]. However, both
rat and rabbit teeth are continually erupting and have an
open apical foramen. These two latter models have an
inherent self-reparative capacity and share more similarity
to human deciduous teeth and permanent teeth with
immature root formation. Therefore, they are well-suited
to studying the differentiation of dental progenitor cells.
The most common experimental protocol involves the
creation of a mechanical pulpal exposure. This technique
fails to replicate the most common clinical scenario in
which the dentin-pulp complex is destroyed by bacterial-
induced inflammation. Therefore, models have been
developed in which pulpal inflammation is induced by
the injection of lipopolysaccharide [25].
D. Research to date
To date, attempts to regenerate lost dental hard tissue have
met with mixed results.Head & Face Medicine 2006, 2:16 http://www.head-face-med.com/content/2/1/16
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a. Growth factor delivery
While intrapulpal implantation of TGF-beta1 can induce
differentiation of odontoblast-like cells and reparative
dentin formation in the immediate vicinity of the
implanted site [26], its usefulness as a pulp capping agent
is limited [27]. Application of insulin-like growth factor-1
(IGF-1) to mechanically exposed pulps appeared to
reduce inflammation, preserve pulp vitality and promote
pulpal repair in the rabbit [23]. In vitro experiments sug-
gest that dentin matrix extract (DME), which contains a
complex mixture of bioactive molecules, is capable of
inducing differentiation of pulp progenitor cells into
odontoblast-like cells [28]. Efforts at forming reparative
dentin in vivo using dentin matrix extract [29-31], supra-
physiologic doses of recombinant BMPs [32,22], bone sia-
loprotein [33] or amelogenin gene splice products [34]
have resulted in either minimal dentin formation or
excessive quantities of ectopic bone-like material that
occlude the pulp canals. In one rat model [32], pulp cap-
ping with MTA produced significantly more dentin sialo-
phosphoprotein (DSP), a marker of dentinoblast
differentiation, compared to recombinant BMP-7. A plau-
sible explanation for these varied results is that the deliv-
ery of a single bolus of a morphogenic protein with a short
in vivo half-life does not provide the sustained delivery of
physiologic levels of these proteins required for complete
hard tissue regeneration. Moreover, it appears that higher
concentrations of some growth factors may have an oppo-
site effect, inducing apoptosis of putative progenitor cells
[29].
b. Stem cell delivery
A number of recent studies have demonstrated that stem
cells, of both dental and non-dental origin, are capable of
inducing odontogenesis and regenerating dentin [35].
Human adult dental pulp contains a population of cells
("dentin pulp stem cells"; DPSCs) with stem cell-like
properties such as self-renewal and the ability to differen-
tiate into adipocytes and neural-like cells [36], but not
chondroblasts [37]. Tooth-like tissues have been engi-
neered by implanting single cell suspensions isolated
from porcine third molar tooth buds seeded onto polyg-
lycolic acid beads into the omenta of athymic rats [38].
While this preliminary research is extremely promising,
one of the disadvantages of these techniques in their cur-
rent state is the inability to regulate the shape and size of
the regenerated tissue [39].
Deciduous teeth [40] contain a population of more
immature multipotent stem cells ("stem cells from
human exfoliated deciduous teeth"; SHED), that in con-
trast to DPSCs, are capable of forming dentin-like struc-
tures but not a complete dentin-pulp complex. Explants
consisting of adult bone marrow stem cells and oral epi-
thelium from E10.0 mouse embryos have the potential to
form crude tooth-like tissues when grown in kidney cap-
sules [41].
Supplementation of autologous tooth-derived progenitor
stem cells with supraphysiologic levels of recombinant
growth factors appears to hold promise for dentin/pulp
regeneration. In a dog model, isolates of autologous pulp-
derived cells, expanded in culture and supplemented with
rhBMP-2, appear to stimulate the differentiation of odon-
toblasts as well as to promote new dentin formation [42].
c. Gene-enhanced tissue engineering for growth factor delivery
To date, only a few groups have actively investigated the
use of GETE in dentin/pulp regeneration. Transfer of
BMP-7 ex vivo transduced autologous dermal fibroblasts
in a collagen hydrogel into an experimentally-induced fer-
ret model of reversible pulpitis induces reparative den-
tinogenesis and regeneration of the dentin-pulp complex
[25]. However, in this same model, in vivo transduction of
inflamed pulpal tissue with recombinant adenovirus con-
taining the BMP-7 cDNA was ineffective at producing den-
tinogenesis.
In vivo ultrasound-mediated delivery of BMP-11 (Growth/
differentiation factor 11) cDNA to mechanically-exposed
canine pulp tissue was effective at promoting significant
amounts of reparative dentin formation in vivo, with min-
imal pulpal inflammation or necrosis [43]. Expression of
dentin sialoprotein mRNA, a marker associated with
odontoblastic differentiation, was confirmed. These find-
ings contrast with earlier results in which gene delivery by
electroporation resulted in thermally-induced pulpal
necrosis [44]. Ex vivo transplantation of BMP-11-trans-
fected autogenous dental pulp stem cells stimulated repar-
ative dentin formation in the dog model [45]. These
transfected dental pulp stem cells expressed markers of
odontoblastic differentiation in vitro.
E. Challenges and potential pitfalls
Prolonged pulpal infection will lead to severe hemody-
namic changes and inflammation, compromising the
vitality of the dentin-pulp complex. In vivo gene therapy
techniques will likely only be effective for dentin regener-
ation/pulp capping situations in which some viable, unin-
fected apical pulpal tissue containing an adequate
number of pulp progenitor stem cells is still present after
all infected/necrotic pulpal tissue has been excavated.
Ex vivo approaches, in which growth factor-enhanced cells
are transplanted into the tooth, might be viable alterna-
tives for those situations in which there is substantial
inflammation. Implanted cells would require a source of
oxygen and nutrients to sustain viability. Therefore the
local wound environment requires the ability to develop
a vascular bed; either from remaining elements of the den-Head & Face Medicine 2006, 2:16 http://www.head-face-med.com/content/2/1/16
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tal pulp or in the presence of a patent apical foramen. The
ability of implanted cells to survive in an animal model of
dental pulp exposure has been previously demonstrated
[43]. Interestingly, in the myocardial injury model, trans-
fection of bone marrow-derived stem cells with the
fibroblast growth factor-2 (FGF-2) gene increases cell sur-
vival under hypoxic conditions [46]. This observation
could potentially be exploited to increase the effectiveness
of GETE approaches for dentin regeneration.
In addition to neovascularization, complete restoration of
the dentin-pulp complex will also require regeneration of
the pulpal nerve supply. The BPMs appear to play a role in
stimulating nerve regeneration, while angiogenesis is reg-
ulated by VEGF.
Key questions regarding our understanding of factors reg-
ulating the dentin-pulp complex remain unanswered. For
example, it is not understood how, under normal physio-
logic conditions, complete mineralization of the pulp is
prevented, while dentin formation continues to occur at
the periphery [47]. As our understanding of these signal
transduction mechanisms increases, additional
approaches for gene-enhanced tissue regeneration of the
dentin-pulp complex will likely be developed.
iii. Gene-based therapies for periodontal 
regeneration
A. Background
The periodontal attachment comprises a heterogeneous
population of tissues and cells that function, in part, to
attach the tooth to the supporting alveolar bone. Addi-
tional functions include homeostasis, repair of damaged
tissue and proprioception. Major components of the per-
iodontium include the gingiva, periodontal ligament
(PDL), cementum and the surrounding alveolar bone.
The word "periodontitis" literally means "inflammation
around the tooth." In dentistry, periodontitis refers to a
microbial-induced inflammation of the structures sur-
rounding and supporting the teeth with resultant destruc-
tion of the attachment fibers and supporting bone that
hold the teeth in the mouth. Left untreated, it can lead to
tooth loss.
Periodontal disease involves a complex interaction, medi-
ated in large part by an individual's host immune
response to microbial colonization of the periodontal
attachment apparatus, modified by host factors such as
tobacco smoking, underlying disease states, level of
plaque control and genetic susceptibility [48]. A number
of studies [49] have shown an apparent causal link
between genetic polymorphisms of the proinflammatory
cytokine interleukin-1 (IL-1) and the severity of periodon-
tal disease in specific populations.
It is estimated that mild periodontitis affects greater than
90% of the adult population [50]. However, attempts at
determining the exact prevalence of periodontitis in adult
populations are complicated by the variability in parame-
ters examined between different researchers. Moderate to
severe periodontal disease, defined loosely as periodontal
attachment loss that predisposes the patient to tooth
mobility and loss, affects at least 15% of adults over the
age of 30 years of age [51]. In the US, the economic cost
of treating and preventing periodontal disease was esti-
mated at $14,300,000,000 in 1999 [51].
B. Conventional techniques for periodontal repair
Currently, much of the armamentarium available to the
periodontist and general dentist is focused on arresting
periodontal disease progression by reducing the microbial
levels in the periodontal attachment apparatus and alter-
ing the local environment to discourage reattachment of
these pathogens. These techniques, which include non-
surgical techniques such as scaling and root planing and
surgical procedures such as open flap debridement for
access and resective techniques, are designed to remove
diseased tissue and promote an ideal environment for per-
iodontal repair. The ultimate goal is to prepare an endo-
toxin and pathogen-free local environment that promotes
reattachment to the root surface. These approaches gener-
ally result in repair, characterized by healing of the wound
site by formation of an epithelial reattachment. This epi-
thelial attachment, known as a long junctional epithelial
attachment, is formed by keratinocytes that migrate into
the pocket from the crevicular epithelium. The principal
disadvantage of these techniques is that they represent
repair of the diseased site with a non-physiologic epithe-
lial attachment. They fail to regenerate a strong attach-
ment between root surface and neighboring alveolar
bone.
The ultimate goal of periodontal therapy remains the
predicable three-dimensional repair of an intact and func-
tional periodontal attachment that replicates its pre-dis-
ease structure. Current approaches to regenerating lost
attachment have been hampered by the necessity to regen-
erate several tissue types: root cementum, alveolar bone
and intervening periodontal ligament in a coordinated
fashion.
C. Research methodologies
Recently, several promising approaches to periodontal tis-
sue regeneration have been developed. Proper evaluation
of the clinical success rates of these different techniques
has been hampered by a lack of consistency in experimen-
tal techniques used to induce periodontal defects among
different groups, as well as disparities in the methods used
to analyze the outcome. Proper evaluation of the validity
of these techniques should ideally follow a sequentialHead & Face Medicine 2006, 2:16 http://www.head-face-med.com/content/2/1/16
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approach involving in vitro experiments, followed by in
vivo confirmation in an animal model, ultimately leading
to human clinical trials. The effectiveness of any perio-
dontal regenerative approach should be evaluated in vivo
by a combination of intraoral radiology, three-dimen-
sional micro computed tomography (microCT), and his-
tologic/immunohistochemical techniques [52].
The most popular animal models used for the assessment
of periodontal regenerative protocols involve [53] liga-
ture-induced periodontal defects in the non-human pri-
mates (especially the cynomolgus and rhesus monkeys,
which share marked similarity to the human periodon-
tium in terms of structure, plaque flora, and inflammatory
infiltrate), and beagle dogs (which have a different micro-
flora and much faster bone turnover rate compared to
humans).
Obvious ethical issues preclude the en bloc harvesting of
tooth, periodontal ligament attachment and supporting
alveolar bone that would be required for microCT and
histologic evaluation in human clinical trials [54]. There-
fore, by necessity, the assessment of efficacy in clinical tri-
als requires a combination of intraoral radiographic
evaluation and clinical assessment of attachment gain.
Attempts to statistically analyze the effectiveness of these
techniques has been hampered by the observation that
some subpopulations appear to respond better to treat-
ment than others.
Identification of the type of cementum produced is also a
vital component of the evaluation of any successful perio-
dontal regenerative procedure. There are four principal
types of cementum [55,56]. Acellular extrinsic fiber
cementum (AEFC) contains extrinsic fibers (Sharpey's fib-
ers), laid down by PDL, and serves to anchor the root to
the PDL. This type of cementum should be viewed as the
"gold standard" in periodontal regeneration. Cellular
mixed stratified cementum (CMSC), found in the apical
and furcation regions of molars areas, consists of a mix-
ture of AEFC and cellular intrinsic fiber cementum. Cellu-
lar intrinsic fiber cementum, known as repair cementum,
is typically seen in association with reparation of resorp-
tion defects. It lacks Sharpey's fibers and therefore has no
direct role in tooth attachment. Acellular afibrillar cemen-
tum, also called coronal cementum, is found only on
enamel at the cementoenamel junction. Its precise func-
tion is unknown.
D. Research to date
a. Bone replacement grafting
Bone replacement grafting techniques, principally using
autogeneic and allogeneic grafts, are widely used in the
clinical setting. Evidence suggests that autogenously har-
vested cancellous bone grafts, obtained from iliac crest,
the maxillary tuberosity or healing tooth extraction sock-
ets, are capable of producing statistically significant bone
fill. The limited ability of cancellous bone grafts to repair
and/or regenerate bone and periodontal attachment
involves at least three separate but distinct mechanisms:
the ability of bone to act as a biocompatible scaffold, the
presence of specific growth factors within the bone matrix,
and, depending on the source of graft material employed,
the existence of a small population of bone marrow stem
cells that may be capable of differentiating into the spe-
cific cells required for bone/periodontal regeneration.
Disadvantages with the use of fresh iliac crest grafts
include root resorption and the requirement for a second
surgical site. Moreover, histological evidence of true peri-
odontal regeneration in these cases has been limited [57].
In many instances, alveolar bone regeneration is seen in
association with the formation of a long junctional epi-
thelium, representing periodontal repair and not true
regeneration.
Limited human clinical studies have demonstrated histo-
logical evidence of periodontal regeneration, primarily
limited to the base of the defect, through the use of decal-
cified freeze-dried allogeneic bone (DFDB) grafts
obtained from commercial tissue banks [58]. Drawbacks
include the possibility of eliciting a host immune
response, the risk of disease transmission, and the appar-
ent wide variability in the concentration of bone and per-
iodontal-inductive agents (and hence biological activity)
between different preparations.
b. Guided tissue regeneration
Guided tissue regeneration (GTR) is an approach to
regaining periodontal attachment loss involving the surgi-
cal implantation of a cell-impermeable barrier between
detoxified root surface and the crevicular epithelium. The
goal is to retard the migration of crevicular epithelium
into the space between the newly prepared root surface
and the neighboring alveolar bone, thereby avoiding the
formation of a long junctional epithelium. Presumably
this affords time for the selective repopulation of the root
surface by cells from within the PDL space. This approach
may also permit putative progenitor cells within the peri-
odontal defect to differentiate into the specific cell types
required for the regeneration of a functional periodontal
attachment under the stimulus of poorly defined signal-
ing/growth factors. A Cochrane review of published stud-
ies [59] suggests that guided tissue regeneration can be
effective at regenerating periodontal attachment to a lim-
ited extent, but the overall response rate is unpredictable.
Differences may be related to variations in the numbers of
putative progenitor stem cells and the concentrations of
appropriate signaling factors in the periodontal defect site
between patients.Head & Face Medicine 2006, 2:16 http://www.head-face-med.com/content/2/1/16
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c. Growth factor delivery
A number of approaches for periodontal regeneration that
are currently being investigated involve direct delivery of
growth factors. The scientific basis behind these newer
periodontal regenerative approaches lies in part with the
existence of putative precursor cells within the vicinity of
the periodontal attachment. These cells are believed to be
capable of differentiating into the more specialized cell
types required for the reconstruction of a functioning per-
iodontal attachment apparatus (osteoblasts, cementob-
lasts, fibroblasts), under the influence of specific growth
factors. Putative growth factors common to both cemen-
tum and bone include [55] members of the TGF-beta
superfamily, such as the BMPs, as well as IGF-I and IGF-II,
platelet-derived growth factors (PDGFs), epidermal
growth factor (EGF), and the fibroblast growth factors
(FGFs). In addition, cementum-derived growth factor
(CGF), an isoform of IGF-I, appears to be cementum-spe-
cific [60]. These growth factors can be further subdivided
into those that stimulate osteogenesis (e.g. bone morpho-
genetic proteins), those that promote cellular differentia-
tion (e.g. platelet-derived growth factor) and angiogenesis
(e.g. vascular endothelial growth factor; [61]), and those
that regulate the epithelial mesenchymal interactions
involved in initial tooth formation (e.g. Embdogain™).
Emdogain™ (Strauman AG, Basel, Switzerland), a mixture
of enamel matrix proteins, primarily amelogenins, iso-
lated from developing porcine teeth, has been approved
by the U.S. Food and Drug Administration (FDA) for
regeneration of angular intrabony periodontal defects.
Although the mode of function is not known, the pro-
posed mechanism behind using enamel matrix proteins is
that these proteins are believed to be involved in forming
the periodontal attachment apparatus during initial tooth
development. The addition of these proteins to periodon-
tal defect sites may be effective at promoting periodontal
regeneration by recapitulating the environment during
initial tooth attachment. Recent studies [62] have shown
that Emdogain™ contains both TGF-beta and BMP growth
factors, that may contribute to its clinical effectiveness. A
systematic review of published clinical trials [63] suggests
that Emdogain™ affords results similar to those seen with
the use of GTR.
Platelet-rich plasma (PRP) is a component of autologous
whole blood isolated following the centrifugation of the
plasma. PRP acts as a source of growth factors including
PDGF and TGF-beta, both of which appear to be critical
growth factors involved in periodontal regeneration. The
availability of several commercial kits to isolate PRP at
chairside has contributed to its increasing popularity
among clinicians. Preliminary studies [64,65] suggest that
while PRP may have limited effectiveness at promoting
periodontal regeneration, results with PRP for bone regen-
eration have been contradictory [66]. Wide differences in
the concentration of growth factors between different
preparations and between different patients may account
for some of the disparate results. Large scale human stud-
ies are required before this technique can be recom-
mended for routine use.
Recombinant human BMP-2 (rhBMP-2) and rhBMP-7
have been extensively investigated as to their ability to
regenerate periodontal structures. Ankylosis has been
observed in some models of periodontal regeneration,
although results have been conflicting. In furcation
defects, BMP-2 caused ankylosis at the cementum-enamel
junction in a dog model [67], whereas, in baboons, BMP-
7 did not [68]. These differences may be related, in part,
to the animal models, type of defect created, whether the
treated teeth are in occlusion, as well as the carriers used
[9]. Other growth factors employed with varying success
have included PDGF +/- IGF-I [69,70], FGF-2 [71], TGF-
beta1 [72], and brain-derived neurotrophic factor [73].
Several reviews detailing the strengths and weaknesses of
these different growth factors for periodontal regeneration
have been written [74-76].
As our understanding of the different growth factors
involved in dental development increases, the number of
potential therapeutic agents will likewise grow. However,
the principal drawback with these techniques is that these
growth factors, which generally have a short in vivo half-
life, are delivered as a single non-physiologic bolus in
most techniques. Development of controlled-release
delivery approaches has the potential to significantly
increase their clinical effectiveness [77].
c. Cell delivery
The exact source of periodontal precursor cells has yet to
be determined, although it is believed that they are most
likely located within the PDL. A population of multipo-
tent postnatal stem cells have been isolated from human
PDL (PDLSCs) that are capable of generating cementum/
PDL-like structures when transplanted into immunodefi-
cient rats [78]. These PDLSCs expressed the cell surface
marker STRO-1, an early mesenchymal stem cell marker,
and have the potential to differentiate into fat cells follow-
ing induction with an adipogenic cocktail. These adult
stem cells can be recovered from cryopreserved solid tis-
sue isolated from the periodontal ligament of extracted
third molars and are likewise able to generate cementum
and periodontal ligament-like structures in vivo [79].
The use of bone marrow-derived stem cells for periodon-
tal regeneration has also been evaluated. Preliminary
results involving 7 patients who received autologous iliac
crest bone marrow cells demonstrated some gain of clini-
cal attachment [80].Head & Face Medicine 2006, 2:16 http://www.head-face-med.com/content/2/1/16
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d. Gene-enhanced periodontal regeneration
The goal of gene-enhanced periodontal regeneration is to
reclaim the lost regenerative capacity within the PDL
space. While GETE can be used in conjunction with stem
cells, this technique has the greatest potential if it can be
adapted for use with easily harvestable fully mature cells
(e.g. gingival fibroblasts, periodontal ligament fibrob-
lasts). These cells are then genetically-enhanced to express
growth factors that are involved in the initial formation of
both dental and periodontal attachment tissues. In short,
this approach is intended to mimic the normal biological
process that occurs as these tissues are formed early in
development. More specifically, transient morphogen
stimulation, combined with local cues in the wound envi-
ronment, primes progenitor cells within the periodontal
ligament to differentiate into the specific cells required for
the production of root cementum, alveolar bone and PDL fib-
ers in a coordinated fashion.
GETE for periodontal regeneration is still in its infancy. A
couple of preliminary studies have confirmed that this is
a promising approach. Syngeneic dermal fibroblasts
transduced ex vivo with an adenoviral vector expressing
BMP-7 (Ad-BMP-7) in a gelatin carrier were implanted
into submerged, surgically-created periodontal-alveolar
bone defects in the rat [81]. Significant bridging of the
alveolar defect was seen in conjunction with new cemen-
tum formation and fibrous connective tissue attachment.
Interestingly, new bone formation occurred through a
process of endochondral ossification. Direct in vivo trans-
fer of PDGF-B stimulated both alveolar bone and cemen-
tum regeneration in a rat acute periodontitis model [82].
E. Challenges and potential pitfalls
It can be seen from the above discussion that successful
regeneration requires the sequential coordination of a
number of tightly-related processes. First, endotoxin con-
tamination of the root surface needs to be reduced. Then,
progenitor cells within the PDL need to differentiate into
several cell types (i.e. osteoblasts, cementoblasts, fibrob-
lasts, and endothelial cells). These cells must subse-
quently synthesize and release their specific cellular
products in a coordinated and sequential manner to ulti-
mately regenerate AEFC and Sharpey's fibers, connecting
the root surface to the alveolar bone and thus regenerating
a functional periodontal ligament.
In the future, the incorporation of biomimetic motifs into
matrices (e.g. addition of cementum-derived attachment
protein, a cementum-derived protein that appears to pro-
mote adhesion of mineral-forming mesenchymal cells to
root cementum; [83] holds significant potential for
increasing the success rate of periodontal regenerative
protocols.
A number of unknowns remain to be answered before
ideal conditions for periodontal regeneration can be
developed. For example, the specific factors that induce
differentiation along cementoblast lineage, as well as the
origin of cementoblasts, are not known [55].
v. Practical considerations and future prospects
While it is anticipated that in the future, gene-enhanced
tissue engineering approaches will afford great potential
for both dentin-pulp and periodontal regeneration, this
approach would currently face significant regulatory hur-
dles prior to government approval. With the continued
development of improved methods for gene delivery to
cells as well as advances in our knowledge of the molecu-
lar basis of tooth formation and periodontal homeostasis,
it is reasonable to anticipate that a simple chairside proto-
col could be developed in the future. This might involve
either the direct delivery of the DNA of interest to the pul-
pal/periodontal tissue, or the isolation of a small amount
of gingival tissue from the patient, transduction/transfec-
tion of the DNA at chairside, and reimplantion of the
gene-enhanced cells into the tooth or periodontal liga-
ment space.
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